Genmab A/S
NASDAQ:GMAB

Watchlist Manager
Genmab A/S Logo
Genmab A/S
NASDAQ:GMAB
Watchlist
Price: 22.2 USD 1.79% Market Closed
Market Cap: 14.1B USD

EV/OCF
Enterprise Value to OCF

-1 632.6
Current
36.6
Median
5.2
Industry
Lower than median
Lower than industry value

Enterprise Value to Operating Cash Flow (EV/OCF) ratio is a valuation multiple that measures the value of a company, debt included, to the operating cash flow it generates.

EV/OCF
-1 632.6
=
Enterprise Value
88.5B DKK
/
Operating Cash Flow
-54.2m DKK
 
DK
Genmab A/S
NASDAQ:GMAB
Average EV/OCF: 19.2
Negative Multiple: -1 632.6
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -217 699.9
US
Abbvie Inc
NYSE:ABBV
24.2
US
Amgen Inc
NASDAQ:AMGN
16.5
US
Gilead Sciences Inc
NASDAQ:GILD
14.9
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -111.9
US
E
Epizyme Inc
F:EPE
Negative Multiple: -517.2
AU
CSL Ltd
ASX:CSL
28.4
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
12.1
US
S
Seagen Inc
F:SGT
Negative Multiple: -81.1
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -833.4

EV/OCF Forward Multiples

Forward EV/OCF multiple is a version of the EV/OCF ratio that uses forecasted operating cash flow for the EV/OCF calculation. 1-Year, 2-Years, and 3-Years forwards use operating cash flow forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/OCF
N/A
2-Years Forward
EV/OCF
N/A
3-Years Forward
EV/OCF
N/A